1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 United States Biomarkers Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 United States Biomarkers Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 United States Biomarkers Market - Breakup by Product
6.1 Consumables
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Forecast (2024-2032)
6.2 Services
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Forecast (2024-2032)
6.3 Software
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2018-2023)
6.3.3 Market Forecast (2024-2032)
7 United States Biomarkers Market - Breakup by Type
7.1 Efficacy Biomarkers
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Forecast (2024-2032)
7.2 Safety Biomarkers
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Forecast (2024-2032)
7.3 Validation Biomarkers
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2018-2023)
7.3.3 Market Forecast (2024-2032)
8 United States Biomarkers Market - Breakup by Disease
8.1 Cancer
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Forecast (2024-2032)
8.2 Cardiovascular Disorders
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Forecast (2024-2032)
8.3 Neurological Disorders
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2018-2023)
8.3.3 Market Forecast (2024-2032)
8.4 Immunological Disorders
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2018-2023)
8.4.3 Market Forecast (2024-2032)
8.5 Renal Disorders
8.5.1 Overview
8.5.2 Historical and Current Market Trends (2018-2023)
8.5.3 Market Forecast (2024-2032)
8.6 Others
8.6.1 Historical and Current Market Trends (2018-2023)
8.6.2 Market Forecast (2024-2032)
9 United States Biomarkers Market - Breakup by Application
9.1 Diagnostics
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2018-2023)
9.1.3 Market Forecast (2024-2032)
9.2 Drug Discovery and Development
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2018-2023)
9.2.3 Market Forecast (2024-2032)
9.3 Personalized Medicine
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2018-2023)
9.3.3 Market Forecast (2024-2032)
9.4 Others
9.4.1 Historical and Current Market Trends (2018-2023)
9.4.2 Market Forecast (2024-2032)
10 United States Biomarkers Market - Breakup by End User
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2018-2023)
10.1.3 Market Forecast (2024-2032)
10.2 Diagnostic and Research Laboratories
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2018-2023)
10.2.3 Market Forecast (2024-2032)
10.3 Hospitals and Specialty Clinics
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2018-2023)
10.3.3 Market Forecast (2024-2032)
10.4 Others
10.4.1 Historical and Current Market Trends (2018-2023)
10.4.2 Market Forecast (2024-2032)
11 United States Biomarkers Market – Breakup by Region
11.1 Northeast
11.1.1 Overview
11.1.2 Historical and Current Market Trends (2018-2023)
11.1.3 Market Breakup by Product
11.1.4 Market Breakup by Type
11.1.5 Market Breakup by Disease
11.1.6 Market Breakup by Application
11.1.7 Market Breakup by End User
11.1.8 Key Players
11.1.9 Market Forecast (2024-2032)
11.2 Midwest
11.2.1 Overview
11.2.2 Historical and Current Market Trends (2018-2023)
11.2.3 Market Breakup by Product
11.2.4 Market Breakup by Type
11.2.5 Market Breakup by Disease
11.2.6 Market Breakup by Application
11.2.7 Market Breakup by End User
11.2.8 Key Players
11.2.9 Market Forecast (2024-2032)
11.3 South
11.3.1 Overview
11.3.2 Historical and Current Market Trends (2018-2023)
11.3.3 Market Breakup by Product
11.3.4 Market Breakup by Type
11.3.5 Market Breakup by Disease
11.3.6 Market Breakup by Application
11.3.7 Market Breakup by End User
11.3.8 Key Players
11.3.9 Market Forecast (2024-2032)
11.4 West
11.4.1 Overview
11.4.2 Historical and Current Market Trends (2018-2023)
11.4.3 Market Breakup by Product
11.4.4 Market Breakup by Type
11.4.5 Market Breakup by Disease
11.4.6 Market Breakup by Application
11.4.7 Market Breakup by End User
11.4.8 Key Players
11.4.9 Market Forecast (2024-2032)
12 United States Biomarkers Market – Competitive Landscape
12.1 Overview
12.2 Market Structure
12.3 Market Player Positioning
12.4 Top Winning Strategies
12.5 Competitive Dashboard
12.6 Company Evaluation Quadrant
13 Profiles of Key Players
13.1 Company A
13.1.1 Business Overview
13.1.2 Services Offered
13.1.3 Business Strategies
13.1.4 SWOT Analysis
13.1.5 Major News and Events
13.2 Company B
13.2.1 Business Overview
13.2.2 Services Offered
13.2.3 Business Strategies
13.2.4 SWOT Analysis
13.2.5 Major News and Events
13.3 Company C
13.3.1 Business Overview
13.3.2 Services Offered
13.3.3 Business Strategies
13.3.4 SWOT Analysis
13.3.5 Major News and Events
13.4 Company D
13.4.1 Business Overview
13.4.2 Services Offered
13.4.3 Business Strategies
13.4.4 SWOT Analysis
13.4.5 Major News and Events
13.5 Company E
13.5.1 Business Overview
13.5.2 Services Offered
13.5.3 Business Strategies
13.5.4 SWOT Analysis
13.5.5 Major News and Evens
Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.
14 United States Biomarkers Market - Industry Analysis
14.1 Drivers, Restraints, and Opportunities
14.1.1 Overview
14.1.2 Drivers
14.1.3 Restraints
14.1.4 Opportunities
14.2 Porters Five Forces Analysis
14.2.1 Overview
14.2.2 Bargaining Power of Buyers
14.2.3 Bargaining Power of Suppliers
14.2.4 Degree of Competition
14.2.5 Threat of New Entrants
14.2.6 Threat of Substitutes
14.3 Value Chain Analysis
15 Appendix